H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue Growth

On the different hand, the institution reported a nett nonaccomplishment of $125.9 million, oregon $0.71 per diluted share, which was greater than H.C. Wainwright’s expected nonaccomplishment of $84.7 million. The steadfast stated that the operating nonaccomplishment has accrued successful examination to erstwhile quarters.

Tempus AI, Inc. (NASDAQ:TEM) expanded a fig of partnerships during the quarter, including its collaboration with Gilead to connection enterprise-wide accessibility to its AI-driven Lens level and a multi-year strategical concern with Merck to expedite biomarker find and development. In addition, the institution revealed results from the ALERT proceedings with Medtronic, which showed that its AI-driven EHR alerts improved life-saving bosom valve operations by 40%.

Tempus AI, Inc. (NASDAQ:TEM) is simply a healthcare exertion institution that uses artificial quality to beforehand precision medicine.

While we admit the imaginable of TEM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.